Earnings above expectations for Abbott, sales up
The U.S. Abbott Laboratories has reported quarterly earnings slightly better than expected, driven by strong growth in sales of prescription drugs, medical devices and nutritional products.
Net income for the second quarter was virtually unchanged at 1.29 billion dollars (one billion euros), or 83 cents per share.
Excluding items, earnings in the quarter rose 13.5% to $ 1.01 per share. Analysts on average expected $ 1.00 according to Thomson Reuters consensus I / B / E / S.
Worldwide sales increased 17.8% to 8.82 billion dollars, a result consistent with the consensus that almost amounted to 8.84 billion dollars.
- LG earnings fall, weak sales in telephony
- The organic growth of L'Oreal slows in Q2
- Better than expected half-year for Heineken
- Air Liquide's growth and boosts the share of emerging
- Decrease in quarterly earnings from Nokia, the DG under pressure
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.